文献速递生殖医学

新型冠状病毒感染疫苗接种对体外受精后活产率的影响

Impact of coronavirus disease 2019 vaccination on live birth rates after in vitro fertilization.
PubMed 文献 · Fertil Steril · 2023-12-01

该回顾性队列研究在学术生育中心纳入2020年1月1日至2021年12月31日接受新鲜或冷冻胚胎移植的患者,比较接种与未接种新冠疫苗者的妊娠结局。新鲜周期中接种与未接种者活产率无显著差异;冷冻胚胎移植周期中接种者阳性hCG、临床妊娠和活产率均高于未接种者。

要点

  • 冷冻胚胎移植周期中,接种者活产率高于未接种者(aOR 2.31,95%CI 1.60-3.32)。
  • 新鲜周期中,接种与未接种者的阳性hCG、临床妊娠和活产率均无显著差异。
  • 新鲜周期中两组获卵数、卵母细胞成熟率、受精率和囊胚利用率无显著差异。

核心结论

  • 冷冻胚胎移植前接种新冠疫苗的患者生化妊娠、临床妊娠和活产率更高;新鲜周期中接种与妊娠或活产率无关。

研究设计与样本

  • 回顾性队列研究,在学术生育中心纳入2020年1月1日至2021年12月31日的新鲜或冷冻胚胎移植周期。
  • 接种定义:周期启动前完成2剂方案(辉瑞或莫德纳)或1剂方案(强生/杨森)。
  • 新鲜周期:未接种709例,接种648例;冷冻胚胎移植周期:未接种264例,接种423例。

主要发现

  • 新鲜周期中,接种与未接种者获卵数、卵母细胞成熟率、受精率和囊胚利用率均无统计学显著差异。
  • 新鲜周期调整多因素分析:阳性hCG的aOR 1.37(95%CI 0.84-2.25),临床妊娠aOR 1.22(95%CI 0.73-2.03),活产aOR 1.37(95%CI 0.79-2.25),均无统计学显著差异。
  • 冷冻胚胎移植周期中,接种者阳性hCG(aOR 1.54,95%CI 1.08-2.20)、临床妊娠(aOR 1.80,95%CI 1.27-2.56)和活产(aOR 2.31,95%CI 1.60-3.32)均高于未接种者。

关键数值与推荐

  • 新鲜周期每胚胎移植活产aOR 1.37(95%CI 0.79-2.25),无统计学显著差异。
  • 冷冻胚胎移植周期每胚胎移植活产aOR 2.31(95%CI 1.60-3.32),接种者高于未接种者。
  • 冷冻胚胎移植周期每胚胎移植临床妊娠aOR 1.80(95%CI 1.27-2.56),接种者高于未接种者。
  • 冷冻胚胎移植周期每胚胎移植阳性hCG aOR 1.54(95%CI 1.08-2.20),接种者高于未接种者。

临床怎么用

  • 原文结论认为本研究为支持尝试妊娠患者接种新冠疫苗提供了证据。
  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate coronavirus disease 2019 (COVID-19) vaccination on the live birth rates in patients who underwent in vitro fertilization. DESIGN: Retrospective cohort study. SETTING: Academic fertility practice. PATIENT(S): Patients who underwent fresh or frozen embryo transfer cycles at an academic center between January 1, 2020, and December 31, 2021. INTERVENTION(S): Coronavirus disease 2019 vaccination, defined as completing a 2-dose regimen (Pfizer or Moderna) or 1-dose regimen (Johnson & Johnson/Janssen) before cycle initiation. MAIN OUTCOME MEASURE(S): The primary outcome was the live birth rate per embryo transfer. The secondary outcomes included positive human chorionic gonadotropin (hCG) and clinical pregnancy rates per embryo transfer. The outcomes from cycles among vaccinated and unvaccinated patients were compared. Descriptive statistics were used to analyze demographic and cycle characteristics using the Student t test and Wilcoxon rank sum, Pearson chi-square, and Fisher exact tests as appropriate for univariate analysis. Generalized estimating equation models were used to examine the strength of the relationship between vaccination status and pregnancy outcomes. RESULT(S): Among 709 unvaccinated and 648 vaccinated fresh cycles, no statistically significant differences were observed between the number of oocytes retrieved, oocyte maturity, fertilization, and blastocyst utilization rates. In the adjusted multivariate analysis, no statistically significant differences were noted between fresh cycles among vaccinated patients compared with those among unvaccinated patients with the rates of positive hCG (adjusted odds ratio [aOR], 1.37; 95% confidence interval [CI], 0.84-2.25), clinical pregnancy (aOR, 1.22; 95% CI, 0.73-2.03), or live birth (aOR, 1.37; 95% CI, 0.79-2.25) per embryo transfer. Among 264 unvaccinated and 423 vaccinated frozen embryo transfer (FET) cycles, vaccinated patients had higher odds of positive hCG (aOR, 1.54; 95% CI, 1.08-2.20), clinical pregnancy (aOR, 1.80; 95% CI, 1.27-2.56), and live birth (aOR, 2.31; 95% CI, 1.60-3.32) per embryo transfer than unvaccinated patients. CONCLUSION(S): Patients who were COVID-19 vaccinated before FET had higher rates of biochemical pregnancy, clinical pregnancy, and live birth. Vaccination was not associated with the pregnancy or live birth rates after fresh cycles. This study contributes to evidence supporting COVID-19 vaccination for patients attempting pregnancy.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Applebaum J, Humphries LA, Kravitz E, et al. Impact of coronavirus disease 2019 vaccination on live birth rates after in vitro fertilization. Fertil Steril. 2023. PMID: 38043842. doi:10.1016/j.fertnstert.2023.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。